Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,435,082
-
Total 13F shares
-
23,756,250
-
Share change
-
-390,714
-
Total reported value
-
$277,238,057
-
Price per share
-
$11.67
-
Number of holders
-
108
-
Value change
-
-$6,250,112
-
Number of buys
-
49
-
Number of sells
-
42
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2015
As of 30 Sep 2015,
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,756,250 shares.
The largest 10 holders included
WYNNEFIELD CAPITAL INC, DIMENSIONAL FUND ADVISORS LP, NWQ INVESTMENT MANAGEMENT COMPANY, LLC, Boston Partners, ARIEL INVESTMENTS, LLC, ROYAL BANK OF CANADA, ROYCE & ASSOCIATES LLC, KILLEN GROUP INC, VANGUARD GROUP INC, and HEARTLAND ADVISORS INC.
This page lists
108
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.